Pluto Bioinformatics

GSE132529: Effective treatment of immune checkpoint blockade-resistant tumors by pharmacological activation of estrogen receptor beta

Bulk RNA sequencing

In this study, we examined the differential RNA profile of LY500307 plus PD-1-treated 4T1 cells and PD-1-treated 4T1 cells compared with control 4T1 cells SOURCE: Shengtao Zhou (taotaovip2005@163.com) - West China Second Hospital, Sichuan University